State-of-the-art and future directions for extinction as a translational model for fear and anxiety.

Michelle G Craske, Dirk Hermans, Bram Vervliet
Author Information
  1. Michelle G Craske: Department of Psychology, University of California, 405 Hilgard Avenue, Los Angeles, CA, USA craske@psych.ucla.edu. ORCID
  2. Dirk Hermans: Center for Excellence on Generalization, University of Leuven, Leuven, Belgium.
  3. Bram Vervliet: Center for Excellence on Generalization, University of Leuven, Leuven, Belgium.

Abstract

Through advances in both basic and clinical scientific research, Pavlovian fear conditioning and extinction have become an exemplary translational model for understanding and treating anxiety disorders. Discoveries in associative and neurobiological mechanisms underlying extinction have informed techniques for optimizing exposure therapy that enhance the formation of inhibitory associations and their consolidation and retrieval over time and context. Strategies that enhance formation include maximizing prediction-error correction by violating expectancies, deepened extinction, occasional reinforced extinction, attentional control and removal of safety signals/behaviours. Strategies that enhance consolidation include pharmacological agonists of NMDA (i.e. d-cycloserine) and mental rehearsal. Strategies that enhance retrieval include multiple contexts, retrieval cues, and pharmacological blockade of contextual encoding. Stimulus variability and positive affect are posited to influence the formation and the retrieval of inhibitory associations. Inhibitory regulation through affect labelling is considered a complement to extinction. The translational value of extinction will be increased by more investigation of elements central to extinction itself, such as extinction generalization, and interactions with other learning processes, such as instrumental avoidance reward learning, and with other clinically relevant cognitive-emotional processes, such as self-efficacy, threat appraisal and emotion regulation, will add translational value. Moreover, framing fear extinction and related processes within a developmental context will increase their clinical relevance.This article is part of a discussion meeting issue 'Of mice and mental health: facilitating dialogue between basic and clinical neuroscientists'.

Keywords

References

  1. Learn Motiv. 2007 Feb;38(1):56-74 [PMID: 19132143]
  2. Behav Res Ther. 2005 Mar;43(3):357-71 [PMID: 15680931]
  3. J Behav Ther Exp Psychiatry. 2015 Mar;46:141-50 [PMID: 25460260]
  4. J Behav Ther Exp Psychiatry. 2017 Jun;55:66-72 [PMID: 27915159]
  5. J Exp Psychol Anim Behav Process. 2006 Apr;32(2):135-44 [PMID: 16634656]
  6. PLoS One. 2014 Jan 16;9(1):e86462 [PMID: 24454969]
  7. Depress Anxiety. 2015 Apr;32(4):239-53 [PMID: 25703487]
  8. Neurobiol Learn Mem. 2012 Jul;98(1):17-24 [PMID: 22543193]
  9. Soc Cogn Affect Neurosci. 2014 Aug;9(8):1134-42 [PMID: 23748500]
  10. Psychol Rev. 1980 Nov;87(6):532-52 [PMID: 7443916]
  11. J Anxiety Disord. 2011 Mar;25(2):284-92 [PMID: 21146358]
  12. Biol Psychiatry. 2013 Feb 15;73(4):345-52 [PMID: 22981655]
  13. J Behav Ther Exp Psychiatry. 2012 Jun;43(2):737-44 [PMID: 22101140]
  14. Behav Neurosci. 2002 Dec;116(6):1075-83 [PMID: 12492306]
  15. Clin Psychol Rev. 2015 Dec;42:72-82 [PMID: 26319194]
  16. Psychol Bull. 1993 Jul;114(1):80-99 [PMID: 8346330]
  17. J Behav Ther Exp Psychiatry. 2016 Mar;50:277-82 [PMID: 26497447]
  18. Cogn Emot. 2017 Jun;31(4):712-725 [PMID: 26907670]
  19. Transl Psychiatry. 2011 Jun 07;1:e12 [PMID: 22832428]
  20. J Exp Child Psychol. 2017 Jul;159:263-278 [PMID: 28347936]
  21. Mol Psychiatry. 2017 Jan;22(1):24-36 [PMID: 27752080]
  22. Neuropsychopharmacology. 2008 Jan;33(1):56-72 [PMID: 17882236]
  23. Front Behav Neurosci. 2012 Jul 16;6:41 [PMID: 22811661]
  24. Learn Mem. 2002 Nov-Dec;9(6):402-7 [PMID: 12464700]
  25. Depress Anxiety. 2015 Dec;32(12):892-9 [PMID: 26372291]
  26. Psychol Sci. 2007 May;18(5):421-8 [PMID: 17576282]
  27. Soc Cogn Affect Neurosci. 2015 Feb;10(2):199-208 [PMID: 24813437]
  28. J Neurosci. 2010 Apr 7;30(14):4990-8 [PMID: 20371819]
  29. Learn Mem. 2004 Sep-Oct;11(5):495-500 [PMID: 15466299]
  30. Emotion. 2012 Dec;12(6):1393-7 [PMID: 22775125]
  31. Biol Psychiatry. 2014 Jun 1;75(11):864-72 [PMID: 24094510]
  32. J Behav Ther Exp Psychiatry. 2018 Mar;58:18-28 [PMID: 28777975]
  33. J Consult Clin Psychol. 1995 Oct;63(5):754-65 [PMID: 7593868]
  34. Behav Res Ther. 2014 Nov;62:3-16 [PMID: 25115195]
  35. Neuropsychopharmacology. 2016 Dec;41(13):3092-3102 [PMID: 27417516]
  36. Behav Res Ther. 2015 Aug;71:65-75 [PMID: 26073498]
  37. Neurobiol Learn Mem. 2014 Feb;108:65-77 [PMID: 24269353]
  38. Biol Psychiatry. 2002 Nov 15;52(10):976-86 [PMID: 12437938]
  39. Behav Res Ther. 2015 May;68:27-36 [PMID: 25795524]
  40. Am J Psychiatry. 2010 Jan;167(1):47-55 [PMID: 19917595]
  41. Perspect Psychol Sci. 2015 Mar;10(2):176-99 [PMID: 25910388]
  42. J Consult Clin Psychol. 2012 Oct;80(5):773-85 [PMID: 22486408]
  43. Anim Learn Behav. 1978 May;6(2):209-15 [PMID: 680322]
  44. Neuropsychopharmacology. 2016 Jan;41(1):320-34 [PMID: 26294108]
  45. Behav Res Ther. 2008 Sep;46(9):1070-7 [PMID: 18675398]
  46. World Psychiatry. 2016 Oct;15(3):245-258 [PMID: 27717254]
  47. Front Behav Neurosci. 2015 Oct 16;9:270 [PMID: 26528152]
  48. Cogn Emot. 2015;29(4):654-67 [PMID: 24957680]
  49. Psychol Sci. 2013 Nov 1;24(11):2182-90 [PMID: 24022651]
  50. Behav Res Ther. 2000 Oct;38(10):967-83 [PMID: 11004736]
  51. Cogn Emot. 2018 Feb;32(1):167-173 [PMID: 27922320]
  52. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221 [PMID: 28265059]
  53. Cochrane Database Syst Rev. 2015 May 10;(5):CD007803 [PMID: 25957940]
  54. Neuropharmacology. 2012 Feb;62(2):695-704 [PMID: 21377482]
  55. Nature. 2014 Jul 17;511(7509):287-9 [PMID: 25030152]
  56. PLoS One. 2014 Jul 03;9(7):e93519 [PMID: 24991926]
  57. Learn Mem. 2014 Aug 15;21(9):424-40 [PMID: 25128533]
  58. Neurobiol Learn Mem. 2014 Sep;113:25-34 [PMID: 24374132]
  59. Front Psychol. 2015 Jul 08;6:968 [PMID: 26217284]
  60. Psychol Bull. 2004 Nov;130(6):843-57 [PMID: 15535740]
  61. J Exp Psychol Anim Behav Process. 1993 Jan;19(1):77-89 [PMID: 8418218]
  62. Am Psychol. 2000 Mar;55(3):313-7 [PMID: 10743250]
  63. Neuron. 2008 Sep 11;59(5):829-38 [PMID: 18786365]
  64. Behav Res Ther. 2014 Jul;58:10-23 [PMID: 24864005]
  65. Behav Res Ther. 2008 Aug;46(8):954-67 [PMID: 18539262]
  66. Psychol Sci. 2016 Aug;27(8):1051-60 [PMID: 27324266]
  67. Biol Psychiatry. 2009 Feb 1;65(3):220-6 [PMID: 18789433]
  68. J Abnorm Psychol. 2012 May;121(2):315-24 [PMID: 21988452]
  69. Behav Ther. 2006 Mar;37(1):49-60 [PMID: 16942960]
  70. Cogn Emot. 2017 Jun;31(4):687-698 [PMID: 26998883]
  71. Neuropsychopharmacology. 2016 Jan;41(1):58-79 [PMID: 26105142]

MeSH Term

Animals
Anxiety Disorders
Conditioning, Classical
Extinction, Psychological
Fear
Humans
Mice
Translational Research, Biomedical

Word Cloud

Created with Highcharts 10.0.0extinctionfeartranslationalenhanceretrievalclinicalmodelanxietyformationStrategiesincludewillprocessesbasicexposuretherapyinhibitoryassociationsconsolidationcontextpharmacologicalmentalaffectregulationvaluelearningadvancesscientificresearchPavlovianconditioningbecomeexemplaryunderstandingtreatingdisordersDiscoveriesassociativeneurobiologicalmechanismsunderlyinginformedtechniquesoptimizingtimemaximizingprediction-errorcorrectionviolatingexpectanciesdeepenedoccasionalreinforcedattentionalcontrolremovalsafetysignals/behavioursagonistsNMDAied-cycloserinerehearsalmultiplecontextscuesblockadecontextualencodingStimulusvariabilitypositivepositedinfluenceInhibitorylabellingconsideredcomplementincreasedinvestigationelementscentralgeneralizationinteractionsinstrumentalavoidancerewardclinicallyrelevantcognitive-emotionalself-efficacythreatappraisalemotionaddMoreoverframingrelatedwithindevelopmentalincreaserelevanceThisarticlepartdiscussionmeetingissue'Ofmicehealth:facilitatingdialogueneuroscientists'State-of-the-artfuturedirections

Similar Articles

Cited By